You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Therapeutics

Showing 26 - 50 of 8,305
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Personalised Therapeutics @LUMC

Not yet recruiting
  • Adverse Drug Reaction
  • Genetic test for 14 pharmacogenes
  • (no location specified)
Aug 18, 2022

COPD Trial in Beijing (Digital Intervention)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Digital Intervention
  • Beijing, Beijing, China
    China-Japan Friendship hospital
Dec 19, 2022

Endometrial Cancer Trial in Houston (DKN-01, Pembrolizumab)

Not yet recruiting
  • Endometrial Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 27, 2023

Methamphetamine Abuse Trial in Chengdu (Cognitive Behavioral Therapy, Counseling, Approach Bias Modification)

Completed
  • Methamphetamine Abuse
  • Cognitive Behavioral Therapy
  • +3 more
  • Chengdu, Sichuang, China
    Huangshui Township Municipal Government
Nov 29, 2022

MDD, Apathy Trial in New York, White Plains (Targeted Cognitive Training Intervention, General Cognitive Training Intervention)

Not yet recruiting
  • Major Depressive Disorder
  • Apathy
  • Targeted Cognitive Training Intervention
  • General Cognitive Training Intervention
  • New York, New York
  • +1 more
May 17, 2023

Chronic Pain Trial in Vancouver (Spectrum Therapeutics cannabis products)

Active, not recruiting
  • Chronic Pain
  • Spectrum Therapeutics cannabis products
  • Vancouver, British Columbia, Canada
    Burrard Pain Doctors
Aug 11, 2022

Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in United States (TGR-1202, TGR-1202 + Ublituximab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Lymphoma
  • Huntsville, Alabama
  • +16 more
Jul 20, 2022

B-cell Non Hodgkin Lymphoma, Richter's Transformation Trial in United States (Cosibelimab, Cosibelimab + Ublituximab +

Terminated
  • B-cell Non Hodgkin Lymphoma
  • Richter's Transformation
  • Cosibelimab
  • Cosibelimab + Ublituximab + Bendamustine combination
  • Huntsville, Alabama
  • +8 more
Aug 19, 2022

Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)

Recruiting
  • Chronic Kidney Diseases
  • Pruritus
  • Difelikefalin 1 mg Oral Tablet
  • Placebo Oral Tablet
  • Northridge, California
  • +5 more
Dec 21, 2022

Patellofemoral Pain Syndrome Trial in Seongnam-si (MORT-PFPS app, treatment as usual (TAU))

Recruiting
  • Patellofemoral Pain Syndrome
  • MORT-PFPS app
  • treatment as usual (TAU)
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Nov 28, 2022

Chronic Lymphocytic Leukemia Trial in Israel, United States (Ublituximab, Ibrutinib)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +87 more
Apr 25, 2022

Relapsing Remitting Multiple Sclerosis Trial in United States (Ublituximab)

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Ublituximab
  • Pasadena, California
  • +7 more
Aug 19, 2022

CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
Jan 20, 2023

B-Cell Lymphoma Trial in Heidelberg, Melbourne, Nedlands (TG-1801, Ublituximab)

Active, not recruiting
  • B-Cell Lymphoma
  • Heidelberg, Victoria, Australia
  • +2 more
Jan 20, 2023

GERD in Infants Trial (Omeprazole, AR formula)

Not yet recruiting
  • GERD in Infants
  • (no location specified)
Nov 6, 2023

Chemotherapy-Induced Nausea in Genitourinary Cancer and Changes

Not yet recruiting
  • Bladder Cancer
  • +2 more
  • Blood and Tissue
  • Jacksonville, Florida
  • +2 more
Apr 6, 2023

Relapsing Multiple Sclerosis (RMS) Trial in Worldwide (Ublituximab)

Enrolling by invitation
  • Relapsing Multiple Sclerosis (RMS)
  • Ublituximab
  • Pasadena, California
  • +84 more
Mar 22, 2022

Bronchopulmonary Dysplasia Trial in Spain, United States (AT-100, Air-sham)

Recruiting
  • Bronchopulmonary Dysplasia
  • AT-100
  • Air-sham
  • Tucson, Arizona
  • +17 more
Apr 28, 2022

Pruritus, Atopic Dermatitis Trial in Canada, United States (difelikefalin 0.25 mg, difelikefalin 0.5 mg, difelikefalin 1.0 mg)

Completed
  • Pruritus
  • Atopic Dermatitis
  • difelikefalin 0.25 mg
  • +3 more
  • Anniston, Alabama
  • +39 more
Mar 30, 2022

Sleep Wake Disorders, Sleep Disturbance, Sleep-Related Impairment Trial in Pittsburgh (Transdiagnostic Sleep and Circadian

Recruiting
  • Sleep Wake Disorders
  • +2 more
  • Transdiagnostic Sleep and Circadian Intervention (TranS-C), adapted for cardiac rehabilitation
  • Pittsburgh, Pennsylvania
    VA Pittsburgh Healthcare System University Drive Division, Pitts
Aug 23, 2022

Waldenstrom Macroglobulinemia Trial in United States (Umbralisib)

Completed
  • Waldenstrom Macroglobulinemia
  • Washington, District of Columbia
  • +3 more
Oct 19, 2022

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Alpelisib, Tamoxifen, Infigratinib)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Stanford, California
    Stanford University
Nov 16, 2022

Angelman Syndrome Trial in Israel, United States (OV101 Regimen 1, OV101 regimen 2, Placebo)

Completed
Has Results
  • Angelman Syndrome
  • OV101 Regimen 1
  • +2 more
  • Phoenix, Arizona
  • +12 more
Mar 3, 2022

The Pancreas Interception Center for Early Detection,

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +12 more
  • Data collection
  • Tampa, Florida
    Moffitt Cancer Center
Jan 11, 2023

Chronic Kidney Disease(CKD), Uncontrolled Hypertension Trial in Tours (Antihypertensive algorithm, Standard of care)

Not yet recruiting
  • Chronic Kidney Disease(CKD)
  • Uncontrolled Hypertension
  • Antihypertensive algorithm
  • Standard of care
  • Tours, France
    Department of Nephrology, University Hospital of Tours
Feb 8, 2023